SCHEMBL30948433

SCHEMBL30948433

O=C(O)c1ccc2c(c1)CC1(CCNCC1)C2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
KDM4E B2RXH2 3/20 0.44
MAPT P10636 3/20 0.44
POLB P06746 1/20 0.44
BLM P54132 1/20 0.44
GRM1 Q13255 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
MEN1 O00255 1/20 0.44
MAPK1 P28482 1/20 0.44
CYP2C19 P33261 1/20 0.44
KMT2A Q03164 1/20 0.44
TDP2 O95551 1/20 0.42
SRD5A2 P31213 4/20 0.41
KDM1A O60341 3/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA4 P22748 1/20 0.40
CA9 Q16790 1/20 0.40
RXRA P19793 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30948434 1.00 ALDH1A1 (0.46) ALDH1A1KDM4EMAPTPOLBBLM
SCHEMBL21084088 0.91 ALDH1A1 (0.44) ALDH1A1KDM4EMAPTPOLBBLM
SCHEMBL21084148 0.91 ALDH1A1 (0.44) ALDH1A1KDM4EMAPTPOLBBLM
SCHEMBL22789664 0.86 KDM1A (0.44) KDM1AGABRDGABRA1GABRB1GABRA5
SCHEMBL31657080 0.86 KDM1A (0.44) KDM1AGABRDGABRA1GABRB1GABRA5
SCHEMBL18148400 0.84 ALDH1A1 (0.47) ALDH1A1KDM4EMAPTPOLBBLM
SCHEMBL18148340 0.84 ALDH1A1 (0.47) ALDH1A1KDM4EMAPTPOLBBLM
SCHEMBL23811615 0.82 OTUD7B (0.41) ALDH1A1KDM1AGABRDGABRA1GABRB1
SCHEMBL29604529 0.82 OTUD7B (0.41) ALDH1A1KDM1AGABRDGABRA1GABRB1
Trifluoroacetic Acid SCHEMBL29550714 0.81 KDM1A (0.39) KDM1AGABRDGABRA1GABRB1GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250223285-A1 NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS JACOBIO PHARMACEUTICALS CO LTD (CN) 2025-07-10 US claimed
US-12233062-B2 Heterocyclic derivatives useful as SHP2 inhibitors JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2025-02-25 US disclosed
US-20240285617-A1 NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2024-08-29 US disclosed
US-20240245681-A1 HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS JACOBO PHARMACEUTICATS CO LTD (CN) 2024-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250223285-A1 NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS PTPN5, PTPN1, PTPRJ ALDH1A1 2690/4885KDM4E 1233/4885MAPT 4283/4885
US-20240245681-A1 HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS PTPN1, PTPN5, PTPN2 ALDH1A1 2877/4885KDM4E 685/4885MAPT 3358/4885
US-20240285617-A1 NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS PTPN1, PTPN5, PTPN2 ALDH1A1 3226/4885KDM4E 635/4885MAPT 3510/4885
US-12233062-B2 Heterocyclic derivatives useful as SHP2 inhibitors PTPN1, PTPN5, PTPN2 ALDH1A1 2877/4885KDM4E 685/4885MAPT 3358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.